Novocardia is a NYC-based provider of a cardiovascular care delivery platform founded in 2020 by cardiologists Dr. Dan Blumenthal and Dr. Julius Torelli, FACC. The company supports cardiologists in building sustainable practices focused on proactive approaches to treating and preventing cardiovascular disease. It provides partner practices with purpose-built analytics and point-of-care tools designed to improve cardiovascular health. Novocardia facilitates relationships with health plans and primary care partners and implements quality and process improvement efforts and value-focused clinical programs. Additional capabilities include growth and development services, support for traditional back-office functions, and technology-enabled care delivery. The company intends to use the funds to build out its care delivery network of cardiology practices, develop its proprietary actuarial and quality-focused analytics platform, and deploy its cardiovascular disease care model.

Total raised

$54M

Funding rounds

1

Latest round

Series A

Latest activity

Jun 2021